Patent Opposition Database

Join our community to challenge unmerited drug patents

  1. Home
  2. Drugs
  3. Dezecapavir (Vh4004280) And Suricapavir (Vh4011499)

Dezecapavir (VH4004280) and Suricapavir (VH4011499)

Download data Subscribe to updates
Abbreviation
NA
Disease(s)
HIV infection
Background
.pdf
Patent oppositions filed in
Europe (EPO) and Viet Nam

Dezecapavir and Suricapavir are investigational capsid inhibitor class of drugs. Both of these drugs are being explored to be used as long acting injecting formulation compositions.

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Viet Nam28-08-2026Vietnam Network of People Living with HIV (VNP+)Pre-GrantUnder ExaminationCompositionsPCT/IB2022/059780View/Comment
Europe (EPO)13-02-2024AnonymousOtherFiled and SubmittedFormulations WO/2023/062559View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top